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INTRODUCTION
Repeated episodes and prolonged periods of 
hyperglycemia, hypertriglyceridemia or hyperin-
sulinemia may play an important role in the initia-
tion and progression of certain states such as athero-
sclerosis, diabetes, cardiovascular diseases, etc. Post-
prandial periods are characterized also by higher ox-
idation rates in the body which in turn may induce 
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nuclear factor kappa B (NFkB) activation. NFkB-re-
lated pathways are involved in the expression of vari-
ous proinflammatory cytokines, including interleu-
kin 6 (IL-6) and tumor necrosis factor alpha (TNF 
alpha).
Nowadays, there are many studies that present 
the adverse postprandial effects of a high- fat meal 
(HFM). Postprandial hyperlipidemia is an important 
and residual risk factor especially in patients with 
diabetes mellitus and related metabolic disturbanc-
es (23). Vascular endothelial dysfunction is generally 
associated with an increase in the proinflammatory 
markers (1,7). 
Postprandial state, especially the one character-
ized by high levels of triglycerides in the plasma is 
considered to directly induce the levels of proinflam-
matory molecules such as IL-6 and MCP1 secreted 
by adipocytes (13).
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AIM
The aim of the present study is to review the ef-
fects of different challenge tests on the postprandial 
circulation levels of IL-6 and TNF alpha. 
MATERIALS AND METHODS 
The following literature database was used 
as a source for the review: http://journals.plos.org/
plosone; http://www.ncbi.nlm.nih.gov/pubmed. The 
keywords that we have used were: circulating levels 
of IL-6; circulating levels of TNF alpha; oral glucose 
tolerance test; high-fat meal; oral lipid tolerance test; 
postprandial inflammation; postprandial low-grade 
inflammation; metabolic disorders; type 2 diabetes. 
The present review summarizes publications from 
the 2001 – 2016 period. 
OGTT and OLTT Effects Are Measured by 
Clinical Biochemical Biomarkers
The oral glucose tolerance test (OGTT) is wide-
ly used and has been applied to diagnose diabetes for 
decades. It is based on the fact that patients with dia-
betes mellitus have significantly lower ability to me-
tabolize the blood sugar after glucose loading com-
pared to healthy people. OGTT is a tool in the di-
agnostics of diabetes providing accurate assessment 
of the ability of the organism to metabolize glucose, 
much more precise than the measurement of fast-
ing blood sugar levels. It determines the ability of 
the pancreas to secrete insulin and enables the de-
tection of such metabolic disturbances (4). The post-
prandial state is characterized usually by the changes 
in lipid and carbohydrate metabolism, including hy-
pertriglyceridemia, hyperglycemia and reduced con-
centration of HDL-cholesterol (30). These fluctua-
tions are physiological processes which occur many 
times a day in a lipid-enriched diet. Different met-
abolic disturbances, type 2 diabetes (T2D), cardio-
vascular diseases are accompanied by hyperglycemia 
and impaired glucose tolerance and/or dyslipidemia. 
In such conditions increased ratio of LDL/HDL-cho-
lesterol, increased levels of LDL-cholesterol and in-
creased levels of plasma triglycerides are determined 
(15).
The oral lipid tolerance test (OLTT) has been 
widely used to evaluate the postprandial fat load ef-
fect on single markers of inflammation. Postpran-
dial dietary lipids are absorbed in the intestine and 
secreted into the lymph as chylomicrons, rich in tri-
glycerides. After a fatty meal, exogenous fatty acids 
are delivered to the liver by chylomicron remnants 
and may then be reassembled and returned to the 
blood in very low-density lipoproteins (VLDL) (24). 
The hypertriglyceridemia, observed postprandially, 
is due to elevated levels of chylomicrons, VLDL, and 
their respective remnants. In the postprandial phase, 
capillary lipoprotein lipase is highly active and the 
triglyceride-rich lipoproteins are in a competition 
for this enzyme, which is not able to metabolize all 
of them. The non-metabolized lipoprotein complex-
es accumulate and lead to hypertriglyceridemia. The 
increased levels of free fatty acids as a result of a hy-
percaloric diet were regarded as one of the key eti-
ologic components of obesity and related disorders 
such as metabolic syndrome, T2D and low-grade in-
flammation (11). 
OGTT Affects the Cytokine Levels
The oral glucose challenge has been associated 
with a significant increase in the expression of pro-
inflammatory cytokines, including interleukin IL-
1α/β, IL-6, and IL-8 which may result from endoplas-
mic reticulum stress (29). 
In the study of Manning et al. (2008), the IL-6 
levels changed acutely in the postprandial state with 
an initial significant decline of IL-6 levels followed 
by a later rise at the end of OGTT. Similarly, initial 
reduction in plasma IL-6 was observed after an oral 
glucose load and a fatty meal (17). Furthermore, such 
observation was established in lean and obese indi-
viduals (20) as well as in an investigation on over-
weight women (12).
In a later investigation, Manning et al. (2013) 
revealed that plasma IL-6 concentrations were acute-
ly and temporarily decreased at the 30th, 60th and 90th 
minute after an oral glucose load. On the other hand, 
intravenous glucose administration did not notice-
ably affect plasma IL-6 concentrations.
The early decrease of plasma levels of IL-6 af-
ter oral glucose load could be attributed to elevated 
insulin levels at this time (21). Insulin is considered 
to have anti-inflammatory properties, hence it could 
attenuate the pro-inflammatory effect of hypergly-
cemia (3,9). Beisswenger et al. (2011) also speculated 
that an acute increase in the circulating insulin lev-
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els during a meal was the cause of decreased plasma 
IL-6 concentrations in patients with T2D.
OLTT, HFM and Mixed-Meal Challenge Tests 
Affect the Cytokine Levels 
A study of Phillips et al. (2013) suggests that ad-
ministration of a standardized high-fat meal leads to 
a postprandial decrease of IL-6 in subjects with T2D 
and the complete opposite - an increase - in lean sub-
jects (26). 
In a study involving forty-eight people with T2D 
and 32 individuals with normoglycemia the applica-
tion of a mixed-meal challenge test (carbohydrates, 
proteins and fat content 79.1%, 7.7% and 13.2%, re-
spectively) resulted in a postprandial decrease of the 
levels of IL-6 in both groups. Thus, the consumption 
of a carbohydrate-rich meal was associated with a de-
crease in IL-6 among healthy individuals and people 
with T2D (22). In contrast, in overweight individu-
als noticeably increased levels of IL-6 and less pro-
nounced rise of TNF alpha after HFM were observed 
(14,19,25). 
Moher et al. (2014) measured the postprandial 
levels of IL-6 and TNF alpha among normal individ-
uals and people with T2D in an Indian population. 
Their observation was that 4 h after a mixed-meal 
intake the levels of proinflammatory cytokines IL-6 
and TNF alpha were elevated. Hence, the postpran-
dial increase in plasma IL-6 levels was expected and 
was consistent with the general proinflammatory 
and prothrombotic effects of hypertriglyceridemia. 
In a study including OLTT combined with physical 
activity, the levels of plasma IL-6 increased signifi-
cantly throughout the postprandial period in both 
of the examined groups (exercise trial and rest trial). 
However, exercise did not significantly affect benefi-
cially the postprandial IL-6 response in plasma. At 
the same time, exercise significantly lowered the IL-6 
expression in subcutaneous adipose tissue (10). 
Study with rodents established that plasma IL-6 
levels were significantly elevated in the postprandi-
al state and two hours after a meal high in saturat-
ed fat they reached their maximum (18). IL-6 gene 
expression in adipose tissue was higher 2 h after the 
HFM compared to the group of control animals re-
ceiving water ad libitum. At the same time, TNF al-
pha gene expression levels in adipose tissue remained 
very similar, 2 and 6 h after the HFM, both com-
pared to control water load. On the other hand, the 
increase in circulating markers of low-grade inflam-
mation was transient and occurred very early (2 h af-
ter the HFM) when compared to the gradual increase 
in plasma triglycerides (18). 
Poppit et al. (2008) observed that IL-6 levels in-
creased postprandially in response to HFM in lean 
healthy males. Earlier studies revealed an increase of 
both IL-6 and TNF alpha levels in healthy individ-
uals and in patients with T2D. TNF alpha levels in-
creased in patients with metabolic syndrome as well.
In another investigation, there was no associ-
ated rise of postprandial TNF alpha levels in obese 
subjects. Blackburn et al. observed a significant de-
crease of TNF alpha levels in a subgroup of insulin-
sensitive obese men 4 hours after HFM administra-
tion. In contrast, there was no significant response in 
a group of subjects with high HOMA-IR in the same 
study (14).
Mechanism of Postprandial Inflammatory 
Signaling
To examine the mechanisms underlying post-
prandial inflammatory signaling, in vitro studies 
have suggested that triglyceride-rich lipoproteins 
isolated from human plasma after a HFM may di-
rectly induce inflammatory changes affecting both 
endothelial cells and leukocytes (2). Concomitant 
with postprandial endothelial activation, Suganami 
et al. (2007) established that saturated fat could acti-
vate the Toll-like receptor 4/NFκB pathway in a co-
culture of adipocytes and macrophages, suggesting 
a contribution of adipose tissue to postprandial in-
flammation. According to Carpentier et al. (2008), 
saturated fatty acids may activate Toll-like receptors, 
which in turn activate the NFkB pathways including 
in the expression of various proinflammatory cyto-
kines as IL-6 and TNF alpha. 
The study of Magne et al. (2010) of healthy rats 
suggested that an HFM could provoke an early tran-
sient activation of the transcription factor NFκB in 
visceral adipose tissue, which is supported by an 
acute increase in IL-6 gene expression (an NFκB tar-
get gene) in visceral adipose tissue. The postprandial 
activation of NFκB and IL-6 upregulation in adipose 
tissue is consistent with the marked increase of IL-6 
in plasma. Nowadays, it is considered that the viscer-
al adipose tissue, not only a fat mass depot, but an 
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endocrine organ as well is the source of a significant 
part of IL-6 recovered in the circulation.
CONCLUSION
Some studies report that the levels of IL-6 sig-
nificantly increased during and soon after OGGT. 
On the other hand, there are evidences about an ini-
tial decline of IL-6 circulating levels due to a simul-
taneous increase of insulin after a glucose load in 
healthy subjects, later this response being followed 
by a rise in IL-6 levels. High fat load could contrib-
ute to postprandial increase of certain early proin-
flammatory cytokines (IL-6 and TNF alpha) in plas-
ma consistent with the general proinflammatory ef-
fect of hypertriglyceridemia.
In addition, there are some considerations to 
follow in such studies. In particular, circulating lev-
els of IL-6 and TNF alpha cytokines are in concen-
trations as low as picograms per milliliter and there-
fore it is quite challenging to measure them accurate-
ly. In addition, researchers should keep in mind that 
these molecules display marked daily and postpran-
dial variations. Challenge tests still remain quite of 
a challenge to the research community with much 
more to reveal ahead. 
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